Why Viemed Healthcare, Inc.’s (VMD) Stock Is Down 10.53%
As of Thursday, November 05, Viemed Healthcare, Inc.’s VMD share price has dipped by 10.53%, which has investors questioning if this is right time to buy.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Michael Rose
Jenna Brashear
Michael Rose
| Share Statistics | VMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $322.8 | $1,721.2 | 34% |
|
| Shares Out (Mil) | 41.2 | 80.6 | 43% |
|
| Institutional Ownership | 83.8% | 87.6% | 51% |
|
| Float (Mil) | 32.6 | 59.2 | 37% |
|
| Beta | 1.04 | 0.74 | 62% |
|
| Avg Daily Volume (000s) | 222 | 613 | 46% |
|
| Price Change (52-week) |
36.1% | 74.5% | 83% |
|
| Growth | VMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.5% | 10.4% | 74% |
|
| Net Income (5yr) | (13.9%) | (0.5%) | 26% |
|
| EPS (5yr) | (13.9%) | 3.0% | 19 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.3%) | (17.4%) | 40% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | VMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $310 | $1,529 | 36% |
|
| Net Income (TTM) (Mil) | $16 | $33 | 47% |
|
| EPS (TTM) | $0.409 | $0.300 | 51% |
|
| Operating Cash Flow (TTM) (Mil) | $54 | $175 | 46% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $7 | 41% |
|
| Long-Term Debt (Q1) (Mil) | $7 | $419 | 27% |
|
| Enterprise Value (Q1) (Mil) | $348 | $2,427 | 32% |
|
| Valuation | VMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.16 | 2.56 | 61% |
|
| P/E | 22.4 | 25.9 | 63% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | VMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 57.4% | 27.3% | 70% |
|
| Net Margin | 5.0% | 1.4% | 47% |
|
| ROA | 7.6% | 2.4% | 80% |
|
| ROE | 11.0% | 7.3% | 59% |
|
| Liabilities to Assets | 26.8% | 62.3% | 18% |
|
| F-Score | 8 | 5 | 93% |
|
Passing Stock Screens
As of 11/20/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 13.1% |
| +/- S&P 500: | +5.7 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors